Our company has built an integrated innovation and R&D system that deeply combines next-generation DNA sequencing and AI-driven discovery, triple 5D chemical separation, high-throughput in vivo screening, and synthetic biology. Focusing on neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease, as well as sub-health conditions of the nervous system including insomnia, depression, and anxiety, the company is developing novel nutrients and pharmaceuticals with unique mechanisms of action, creating comprehensive integrated solutions that cover both prevention and treatment.
